Minapharm Pharmaceuticals (CAI:MIPH) EPS (Diluted) : E£ (TTM As of Dec. 2022)

View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals EPS (Diluted)?

Minapharm Pharmaceuticals's Earnings per Share (Diluted) for the three months ended in Dec. 2022 was E£0.00.

Minapharm Pharmaceuticals's EPS (Basic) for the three months ended in Dec. 2022 was E£0.00.

Minapharm Pharmaceuticals's EPS without NRI for the three months ended in Dec. 2022 was E£0.00.

During the past 12 months, Minapharm Pharmaceuticals's average EPS without NRIGrowth Rate was -109.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Minapharm Pharmaceuticals EPS (Diluted) Historical Data

The historical data trend for Minapharm Pharmaceuticals's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals EPS (Diluted) Chart

Minapharm Pharmaceuticals Annual Data

Trend

Dec22

Dec23

EPS (Diluted)

51.41

-5.00

Minapharm Pharmaceuticals Quarterly Data
	Dec22	Dec23
EPS (Diluted)	-	-

Competitive Comparison of Minapharm Pharmaceuticals's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Minapharm Pharmaceuticals's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Minapharm Pharmaceuticals's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Minapharm Pharmaceuticals's PE Ratio distribution charts can be found below:

* The bar in red indicates where Minapharm Pharmaceuticals's PE Ratio falls into.

Minapharm Pharmaceuticals EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Minapharm Pharmaceuticals's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-31.988	-	0)	/	11.064
	=	-2.89

Minapharm Pharmaceuticals's Diluted EPS for the quarter that ended in Dec. 2022 is calculated as

Diluted EPS (Q: Dec. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(0	-	0)	/	11.474
	=	0.00

Minapharm Pharmaceuticals (CAI:MIPH) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Minapharm Pharmaceuticals EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Minapharm Pharmaceuticals (CAI:MIPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY

Website

http://www.minapharm.com

Minapharm Pharmaceuticals produces prescription drugs in Egypt and the Middle East. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals (CAI:MIPH) Headlines

No Headlines